Boston University: Clinical Trials

24 trials sponsored by Boston University, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 2 recruiting, 2 terminated, 1 active not recruiting. 24 Phase 3, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 324Completed 17, Recruiting 2, Terminated 2, Active not recruiting 1, Unknown 1, Withdrawn 1
Phase 28Completed 4, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1

Follow Boston University: new trials by email

Trials (filtered) newest first · largest first

All 24 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Oral nitrofurantoin monohydrate/macrocrystals, Placebo - Preterm Birth, Small for Gestational Age (SGA)
Phase 3RecruitingNICHD Global Network for Women's and Children's Health11342025-12-082026-01-22
Prevention of Iron Deficiency Anemia Post-delivery
Ferric carboxymaltose (FCM) and folic acid tablets, Oral iron tablets and folic acid tablets - Postpartum Anemia
Phase 3CompletedNICHD Global Network for Women's and Children's Health48572023-05-302026-07-01
Confirmation of Diet as a Treatment for Gulf War Illness
Dietary Intervention - Gulf War Syndrome, Gulf War Illness
Phase 2 / Phase 3CompletedAmerican University1112023-03-012026-10-05
5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer
Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream - Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ
Phase 2 / Phase 3RecruitingBoston University2002022-10-152025-11-28
Metformin in Alzheimer's Dementia Prevention
Placebo oral tablet, extended release metformin - Mild Cognitive Impairment
Phase 2 / Phase 3Active not recruitingColumbia University3262021-03-222026-08-11
Azithromycin-Prevention in Labor Use Study (A-PLUS)
Azithromycin, Placebo - Maternal Death, Maternal Infections Affecting Fetus or Newborn
Phase 3CompletedNICHD Global Network for Women's and Children's Health587472020-09-012024-10-24
Oral 25-hydroxyvitamin D3 and COVID-19
Oral 25-Hydroxyvitamin D3 - COVID 19
Phase 2 / Phase 3UnknownTehran University of Medical Sciences15002020-04-142020-06-12
Individualizing Automated Closed Loop Glucose Control Through Pharmacokinetic Profiling in an Insulin-Only Bionic Pancreas
Humalog, Novolog, BC222 insulin lispro - Type 1 Diabetes Mellitus
Phase 2 / Phase 3TerminatedMassachusetts General Hospital202019-03-192022-12-09
Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
Delamanid, Linezolid, Levofloxacin - Tuberculosis Multi Drug Resistant Active
Phase 3WithdrawnBoston University2017-08-012017-09-11
High-dose Erythropoietin for Asphyxia and Encephalopathy
Normal saline placebo, Erythropoietin - Neonatal Encephalopathy, Birth Asphyxia
Phase 3CompletedUniversity of California, San Francisco5002017-01-012023-01-30
Testing a Novel Speech Intervention in Minimally Verbal Children With Autism Spectrum Disorder (ASD)
Auditory-Motor Mapping Training, Speech-Repetition Therapy - Autism
Phase 2 / Phase 3CompletedBeth Israel Deaconess Medical Center142014-11-012020-05-19
Testosterone Administration and ACL Reconstruction in Men
Testosterone, Placebo - Muscle Atrophy, ACL Reconstruction
Phase 3CompletedUniversity of Southern California142012-04-012022-03-02
Mifepristone Versus Osmotic Dilator Insertion for Cervical Preparation Prior to Surgical Abortion at 15-18 Weeks
Mifepristone, osmotic dilators - Cervical Preparation
Phase 3CompletedBoston University502011-07-012017-06-14
Effect of Preoperative Buccal Misoprostol on Blood Loss in Second-trimester Dilation and Evacuation Abortion
Misoprostol, Folic acid - Abortion, Blood Loss
Phase 3TerminatedBoston University32011-07-012017-05-30
Zambia Chlorhexidine Application Trial
Chlorhexidine gluconate (4%), Dry cord care - Sepsis
Phase 2 / Phase 3CompletedBoston University775352011-02-012020-08-31
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
Standard Brief Intervention, Enhanced Brief Intervention, Control: Information and Feedback - Drug Usage, Drug Abuse
Phase 3CompletedBoston Medical Center5892009-04-012014-10-02
The Effect of Diflunisal on Familial Amyloidosis
diflunisal, placebo - Familial Amyloid Polyneuropathy, Familial Amyloidosis
Phase 2 / Phase 3CompletedBoston University1302006-02-012017-03-17
Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis
Clopidogrel, Placebo - Kidney Failure, Hemodialysis Fistula Thrombosis
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8772003-01-072025-09-19
Aggrenox Prevention of Access Stenosis
Aggrenox, Placebo - Kidney Failure
Phase 3CompletedNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6492003-01-012017-09-19
Shoe Inserts for Treating Osteoarthritis of the Knee
Shoe Insert - Osteoarthritis, Knee
Phase 3CompletedBoston University902002-02-012013-06-04

Showing 20 of 24. Sign in to see all of them.

Conditions studied

COVID-19 (2)  ·  Patient Acceptance of Health Care (2)  ·  Renal Insufficiency (2)  ·  Alcohol Drinking (1)  ·  Alcoholism (1)  ·  Amyloid Neuropathies, Familial (1)  ·  Amyloidosis (1)  ·  Amyloidosis, Familial (1)  ·  Anemia (1)  ·  Asphyxia Neonatorum (1)  ·  Autistic Disorder (1)  ·  Bacteriuria (1)  ·  Chronic Periodontitis (1)  ·  Cognitive Dysfunction (1)  ·  Cytokine Release Syndrome (1)

Interventions

Folic Acid (2)  ·  Amoxicillin (1)  ·  Anti-Infective Agents, Local (1)  ·  Aspirin (1)  ·  Aspirin, Dipyridamole Drug Combination (1)  ·  Azithromycin (1)  ·  Calcifediol (1)  ·  Clopidogrel (1)  ·  Crisis Intervention (1)  ·  Diet Therapy (1)  ·  Diflunisal (1)  ·  Dipyridamole (1)  ·  Epoetin Alfa (1)  ·  Erythropoietin (1)  ·  Eye Movement Desensitization Reprocessing (1)

Countries

United States (17)  ·  Zambia (4)  ·  Bangladesh (3)  ·  Democratic Republic of the Congo (3)  ·  Guatemala (3)  ·  India (3)  ·  Pakistan (3)  ·  Kenya (2)  ·  Iran (1)  ·  Italy (1)  ·  Japan (1)  ·  Sweden (1)  ·  United Kingdom (1)

Top investigators

Catherine Meyers, M.D. (2)  ·  John W Kusek, Ph.D. (2)  ·  Sarita Sonalkar, MD (2)  ·  Anne D Haffajee, BDS (1)  ·  Arash Shirvani, MD, PhD (1)  ·  Bessel Van Der Kolk, MD (1)  ·  Bilal Fawaz, MD (1)  ·  C. Robert Horsburgh, MD (1)  ·  David T. Felson, MD (1)  ·  Davidson H Hamer, MD (1)  ·  Gottfried Schlaug, MD, PhD (1)  ·  J Max Goodson, DDS, PhD (1)  ·  John L. Berk, MD (1)  ·  Katherine Semrau, PhD (1)

Results publications

PMID 18477783, PMID 35224730, PMID 15908848, PMID 17283347, PMID 17393448, PMID 19458364, PMID 24368466, PMID 25096690, PMID 25481088, PMID 25646254, PMID 26809204, PMID 27693439, PMID 28558800, PMID 28840147, PMID 33757717, PMID 33951036, PMID 34144032, PMID 34298589, PMID 35256443, PMID 35830641, PMID 36757318, PMID 37019334, PMID 37203336, PMID 37418263, PMID 37648383, PMID 37698478, PMID 37742617, PMID 38006967, PMID 38360261, PMID 38984984, PMID 40155105, PMID 40155106, PMID 41527950, PMID 42133947, PMID 42386129

NIH funding

U01DK058982 (2), P60AA013759 (1), P60AR047785 (1), R01AG062624 (1), R01DA025068 (1), R01MH058363 (1), R01NS051306 (1), U24HD092094 (1)